ALGERT GLOBAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,225
+115.2%
24,837
+104.5%
0.10%
+133.3%
Q2 2023$1,034
-67.0%
12,147
-67.9%
0.04%
-69.6%
Q1 2023$3,134
-99.6%
37,879
+228.7%
0.15%
+184.6%
Q3 2022$853,000
-3.7%
11,524
-15.2%
0.05%
-22.4%
Q2 2022$886,000
-3.4%
13,587
-6.3%
0.07%
+11.7%
Q1 2022$917,000
+25.1%
14,497
+4.8%
0.06%
-34.8%
Q4 2021$733,000
-14.4%
13,829
+14.0%
0.09%
-19.3%
Q3 2021$856,00012,1290.11%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders